What should we expect after a surprisingly upbeat first half of Q4's earnings season? Unfortunately, nothing as good as what we've seen already. More
-
-
Sponsored By:
-
Sponsored By:
MRK
3 Healthcare Stocks About to Receive a Booster Shot
Despite the impressive performance of healthcare stocks as a whole, many aren't getting much analyst love. But these three will -- and when they do, look out! More
Sizing Up the Bull Market
A correction may be in the works, but that doesn't mean the bull is dead. Keep an eye on the euro/yen differential to find out when to buy bargains and when to batten down the hatches. More
2 Things to Know About This Bull Market
We're probably looking at a February downturn, but bulls should come back well refreshed and ready to run up the market again. More
Sector Scan: Pharmaceutical Stocks
In the pharmaceutical sector, my scans have revealed four names to buy on strength and one stinker to avoid at all costs or sell if you own it. More
Merck Tumbles on Drug Worries
Shares of Merck fell in Friday morning trading after the company announced that it would delay submitting an osteoporosis drug for FDA approval until 2014. More
Sector Scan: Healthcare Stocks
Find out which 3 healthcare stocks you should be buying, and which 3 to cut your losses on. More
